Hemoglobin A1c levels and the risk of cardiovascular disease in people without known diabetes

Medicine (United States)

Volumn 94, Issue 17, 2015, Pages e785-

  Goto, Atsushi ^a,b   Noda, Mitsuhiko ^a   Matsushita, Yumi ^c   Goto, Maki ^a   Kato, Masayuki ^a   Isogawa, Akihiro ^d   Takahashi, Yoshihiko ^e   Kurotani, Kayo ^a   Oba, Shino ^f   Nanri, Akiko ^a   Mizoue, Tetsuya ^a   Yamagishi, Kazumasa ^g   Yatsuya, Hiroshi ^h   Saito, Isao ⁱ   Kokubo, Yoshihiro ^j   Sawada, Norie ^k   Inoue, Manami ^l   Iso, Hiroyasu ⁿ   Kadowaki, Takashi ^m   Tsugane, Shoichiro ^k  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Departments of Clinical Research   (Japan)

^d MITSUI MEMORIAL HOSPITAL   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^g UNIVERSITY OF TSUKUBA   (Japan)

^h FUJITA HEALTH UNIVERSITY   (Japan)

ⁱ EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^k NATIONAL CANCER CENTER   (Japan)

^l AXA Department of Health and Human Security   (Japan)

^m UNIVERSITY OF TOKYO   (Japan)

ⁿ OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; CARDIOVASCULAR DISEASES; METABOLISM; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84937512446     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000785     Document Type: Article

References (35)

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;385:117-171.
2. Santulli G. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. J Cardiovasc Dis. 2013;1:1-2.
3. Santulli G. Coronary heart disease risk factors and mortality. JAMA. 2012;307:1137-1138.
4. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800-811.
5. Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611-619.
6. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
7. Ikeda F, Doi Y, Ninomiya T, et al. Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study. Cardiovasc Diabetol. 2013;12:164.
8. Nichols GA, Joshua-Gotlib S, Parasuraman S. Glycemic control and risk of cardiovascular disease hospitalization and all-cause mortality. J Am Coll Cardiol. 2013;62:121-127.
9. Zoungas S, Chalmers J, Ninomiya T, et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia. 2012;55:636-643.
10. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481-489.
11. Goto A, Arah OA, Goto M, et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ. 2013;347:f4533.
12. Carson AP, Fox CS, McGuire DK, et al. Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes. Circ Cardiovasc Qual Outcomes. 2010;3:661-667.
13. Aggarwal V, Schneider AL, Selvin E. Low hemoglobin A1c in nondiabetic adults: an elevated risk state? Diabetes Care. 2012;35:2055-2060.
14. Christman AL, Lazo M, Clark JM, et al. Low glycated hemoglobin and liver disease in the U.S. population. Diabetes Care. 2011;34:2548-2550.
15. Rutter MK. Low HbA1c and mortality: causation and confounding. Diabetologia. 2012;55:2307-2311.
16. Tsugane S, Sawada N. The JPHC Study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol. 2014;44:777-782.
17. Noda M, Kato M, Takahashi Y, et al. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC Diabetes Study - suggestion for the threshold for impaired fasting glucose among Japanese. Endocr J. 2010;57:629-637.
18. Kashiwagi A, Kasuga M, Araki E, et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest. 2012;3:39-40.
19. Watanabe S, Tsugane S, Sobue T, et al. Study design and organization of the JPHC Study. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol. 2001;11(6 Suppl):S3-S7.
20. Yamagishi K, Iso H, Kokubo Y, et al. Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities: the JPHC Study. Eur Heart J. 2013;34:1225-1232.
21. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke. Clinical findings. Stroke. 1981;12(2 Pt 2 Suppl 1):I13-I44.
22. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and casefatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
23. Greenland S, O'Rourke K. Meta-analysis. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008::652-682.
24. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
25. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-992.
26. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215-2222.
27. Saito I, Kokubo Y, Yamagishi K, et al. Diabetes and the risk of coronary heart disease in the general Japanese population: the Japan Public Health Center-based prospective (JPHC) Study. Atherosclerosis. 2011;216:187-191.
28. Emerging Risk Factors Collaboration. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014;311:1225-1233.
29. Sakurai M, Saitoh S, Miura K, et al. HbA1c and the Risks for All-Cause and Cardiovascular Mortality in the General Japanese Population: NIPPON DATA90. Diabetes Care. 2013;36:3759-3765.
30. Nishimura R, Nakagami T, Sone H, et al. Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a largescale randomized controlled trial. Cardiovasc Diabetol. 2011;10:58.
31. Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141:413-420.
32. Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010;55:1310-1317.
33. Lee M, Saver JL, Hong KS, et al. Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ. 2012;344:e3564.
34. Santulli G, Cipolletta E, Sorriento D, et al. CaMK4 gene deletion induces hypertension. J Am Heart Assoc. 2012;1:e001081.
35. Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011;124:314-323.